display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/adv melanoma (mML)
mML - NA - all populationmML - L2 - all population
Ipilimumab (10 mg/kg) E1609 ... EORTC 18071 CA184-004 Ascierto ...

Study type: